ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Curcumin from orange-hued turmeric root has long been thought to confer health benefits. Now, Arjuna, an Indian spice company, says it will spend $1.5 million to study the antioxidant compound. The firm is planning 12 university studies covering conditions including depression, Alzheimer’s disease, and cancer. It owns patents on a bioavailable curcumin that it calls BCM-95. The company says it spends 10% of its sales on clinical research on healthy ingredients and employs 40 scientists.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X